LAURA TINDALL: Open Payments
NPI 1639597974 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$181 in 9 payments from 5 companies in 2025. Trend: 2023 $659 · 2024 $30 · 2025 $181
Food & beverage: $181
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $65 |
| Novo Nordisk Inc | 1 | $42 |
| Amgen Inc. | 2 | $30 |
| Abbott Laboratories | 1 | $24 |
| PFIZER INC. | 1 | $20 |
Products named: LEQVIO, Wegovy, REPATHA, PERCLOSE PROSTYLE, ELIQUIS.
Industry payments across IN — which companies pay providers there.
